Cherbel Darido

Cherbel Darido

Company: Peter MacCallum Cancer Centre

Job title: Group Leader and Laboratory Head


Differentiation-paired targeted therapy to improve outcomes in heterogenous head and neck cancer. 12:45 pm

A multi-omic approach identified a functional GRHL3-FLG tumor specific differentiation axis Disruption of this axis confers resistance to PI3K/AKT/mTOR and c-MYC inhibitors The GRHL3-FLG axis may serve as a predictive prognostic and response biomarker to targeted therapy in the clinicRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.